World Bladder Cancer Patient Coalition, Bruxelles, Belgium
Lydia Makaroff , Alex Filicevas , Patrick J. Hensley , Ashish M. Kamat
Background: Bladder cancer patients encounter unique challenges and advantages in urban and rural environments, significantly influencing their path from diagnosis to treatment. While numerous studies explore bladder cancer from clinical and therapeutic perspectives, there is a noticeable gap in research addressing patients' experiences based on geographical locale. This study aims to bridge this gap by offering a comparative analysis of urban versus rural experiences. Methods: The World Bladder Cancer Patient Coalition and IQVIA formulated an online survey, designed to capture the multifaceted experiences of bladder cancer patients. Available in various languages, the survey was accessible from October 2021 to February 2022. Responses underwent systematic analysis, with parameters including gender, time since diagnosis, age, region, and disease stage, forming the sub-analytical categories. Results: We received a total of 1,198 responses from 45 countries. Key findings are summarized in the table, highlighting the comparative experiences of urban and rural patients. Conclusions: Significant disparities emerge between urban and rural bladder cancer patients. Rural patients particularly face prolonged diagnosis times, less clear communication from healthcare providers, and experience greater challenges in accessing treatment. These findings underscore the need for a re-evaluation of communication strategies and healthcare infrastructure, especially in rural areas. This research serves as a stepping stone for further investigations aimed at fostering a more patient-centric approach to bladder cancer care. Limitations to consider involve the inherent biases of online survey distribution and the possibility of certain regions being underrepresented.
Question # | Metric | Urban (%) | Rural (%) |
---|---|---|---|
8 | I saw a family doctor 5 or more times before diagnosis | 9% | 15% |
10 | My wait time for diagnosis was more than 3 months | 23% | 27% |
11 | “Very clear” communication from doctor about testing | 56% | 50% |
11 | "Not at all" clear communication from doctor about testing | 12% | 22% |
30 | I had had a radical cystectomy, and the doctor did not talk to me about treatments that would allow me to keep my bladder | 12% | 20% |
25 | “Very easy” for me to travel for treatment | 55% | 39% |
25 | “Quite difficult” or “very difficult” for me to travel for treatment | 6% | 12% |
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2020 ASCO Quality Care Symposium
First Author: Natasha Kurien
2020 ASCO Quality Care Symposium
First Author: Matthew DePuccio
2023 ASCO Quality Care Symposium
First Author: Christy L. Schneider
2024 ASCO Genitourinary Cancers Symposium
First Author: Liang G Qu